ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,842.91
0.11%
Dow Jones
42,518.28
0.52%
US Dollar vs MXN
20.5571
0.20%
Brent Oil
79.315
-0.48%
Bitcoin
97,301.85
0.83%
Pepperstone
Advertisement
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. USOTC

  6. Parnell Pharmaceuticals Holdings Ltd (CE) (PARNF) Cotización

Parnell Pharmaceuticals Holdings Ltd (CE)

Parnell Pharmaceuticals Holdings Ltd (CE) (PARNF)

USOTC
0.12
0.00
(0.00%)
Cerrado 15 Enero 3:00PM
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
0.12
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
500
0.12 Rango del Día 0.12
0.000001 Rango de 52 semanas 0.35
Capitalización de Mercado [m]
14.445M
Precio Anterior
0.12
Precio de Apertura
0.12
Hora
500
@
0.12
Última hora de negociación
Volumen financiero
US$ 60
Precio Promedio Ponderado
0.12
Volumen promedio (3 m)
31,574
Acciones en circulación
120,377,529
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-2.52
Beneficio por acción (BPA)
-0.05
turnover
35.43M
Beneficio neto
-5.74M

Acerca de Parnell Pharmaceuticals Holdings Ltd (CE)

Parnell (OTC: PARNF) is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal and human health solutions. Parnell is a technology and clinical science leader in dairy reproduction, marketing its proprietary brands estroPLAN and GONAbreed... Parnell (OTC: PARNF) is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal and human health solutions. Parnell is a technology and clinical science leader in dairy reproduction, marketing its proprietary brands estroPLAN and GONAbreed via its dedicated sales force and digital technology mySYNCH in the USA and Australia-New Zealand, and via distributors in other markets. Parnell has a rapidly growing contract manufacturing business supplying industry majors with specialized sterile injectable products. In companion animal, Parnell manufactures and markets its proprietary canine osteoarthritis brands Zydax and Glyde. For more information on the company and its products, please visit www.parnell.com. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.parnell.com
Sede
Sydney, New South Wales, Aus
Fundado
-
Parnell Pharmaceuticals Holdings Ltd (CE) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker PARNF. The last closing price for Parnell Pharmaceuticals (CE) was US$0.12. Over the last year, Parnell Pharmaceuticals (CE) shares have traded in a share price range of US$ 0.000001 to US$ 0.35.

Parnell Pharmaceuticals (CE) currently has 120,377,529 shares in issue. The market capitalisation of Parnell Pharmaceuticals (CE) is US$14.45 million. Parnell Pharmaceuticals (CE) has a price to earnings ratio (PE ratio) of -2.52.

PARNF Últimas noticias

Más noticias

Parnell Pharmaceuticals Holdings Ltd Files Form 25, Voluntarily Delisting Its Shares From NASDAQ

OVERLAND PARK, Kan., Dec. 19, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

19 Diciembre 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces Intention To Move From the NASDAQ OMX Global Market and Expects To Move To the...

OVERLAND PARK, Kan., Dec. 09, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

09 Diciembre 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces $20 Million Secured Term Loan Facility

OVERLAND PARK, Kan., Nov. 22, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...

22 Noviembre 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Nine-Month Period Ended September 30, 2016

OVERLAND PARK, Kansas, Nov. 02, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

02 Noviembre 2016
GlobeNewswire Inc.

Parnell to Report Financial Results for the Nine Months Ended September 30, 2016 on November 2, 2016

OVERLAND PARK, Kan., Oct. 27, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...

27 Octubre 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Six-Month Period Ended June 30, 2016

OVERLAND PARK, Kan., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

04 Agosto 2016
GlobeNewswire Inc.

Parnell to Report Financial Results for the Six Months Ended June 30, 2016 on August 4, 2016

OVERLAND PARK, Kan., July 26, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...

26 Julio 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces Contract Manufacturing Agreement with Merial

OVERLAND PARK, Kan., May 31, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

31 Mayo 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces Pricing of an Underwritten Public Offering of Common Stock

OVERLAND PARK, Kan., May 12, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

12 Mayo 2016
GlobeNewswire Inc.

Parnell Pharmaceuticals Holdings Ltd Announces First Quarter Business Update

Parnell continues to grow rapidly with revenue increasing 43% for the three months ended March 31, 2016OVERLAND PARK, Kan., April 22, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings...

22 Abril 2016
GlobeNewswire Inc.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1000.120.120.12451950.12CS
4-0.23-65.71428571430.350.350.082273080.12829718CS
120.071400.050.350.05315740.08762036CS
260.11991199000.00010.351.0E-6222440.08610534CS
520.119999119999001.0E-60.351.0E-6156250.08387349CS
1560.1198599000.00020.351.0E-6133380.02869895CS
2600.019.090909090910.110.891.0E-6124510.21521886CS

PARNF - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Parnell Pharmaceuticals (CE)?
El precio actual de las acciones de Parnell Pharmaceuticals (CE) es US$ 0.12
¿Cuántas acciones de Parnell Pharmaceuticals (CE) están en circulación?
Parnell Pharmaceuticals (CE) tiene 120,377,529 acciones en circulación
¿Cuál es la capitalización de mercado de Parnell Pharmaceuticals (CE)?
La capitalización de mercado de Parnell Pharmaceuticals (CE) es USD 14.45M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Parnell Pharmaceuticals (CE)?
Parnell Pharmaceuticals (CE) ha negociado en un rango de US$ 0.000001 a US$ 0.35 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Parnell Pharmaceuticals (CE)?
El ratio precio/beneficio de Parnell Pharmaceuticals (CE) es -2.52
¿Cuál es el ratio de efectivo a ventas de Parnell Pharmaceuticals (CE)?
El ratio de efectivo a ventas de Parnell Pharmaceuticals (CE) es 0.41
¿Cuál es la moneda de reporte de Parnell Pharmaceuticals (CE)?
Parnell Pharmaceuticals (CE) presenta sus resultados financieros en AUD
¿Cuál es el último ingresos anual de Parnell Pharmaceuticals (CE)?
El último ingresos anual de Parnell Pharmaceuticals (CE) es AUD 35.43M
¿Cuál es el último beneficio anual de Parnell Pharmaceuticals (CE)?
El último beneficio anual de Parnell Pharmaceuticals (CE) es AUD -5.74M
¿Cuál es la dirección registrada de Parnell Pharmaceuticals (CE)?
La dirección registrada de Parnell Pharmaceuticals (CE) es UNIT 4 CENTURY ESTATE, 476 GARDENERS ROAD, ALEXANDRIA, SYDNEY, NEW SOUTH WALES, 2015
¿Cuál es la dirección del sitio web de Parnell Pharmaceuticals (CE)?
La dirección del sitio web de Parnell Pharmaceuticals (CE) es www.parnell.com
¿En qué sector industrial opera Parnell Pharmaceuticals (CE)?
Parnell Pharmaceuticals (CE) opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
RDRSFRDARS Inc (CE)
US$ 0.001
(99,900.00%)
2.08k
DMTKQDermTech Inc (CE)
US$ 0.0005
(49,900.00%)
2k
COUVCorporate Universe Inc (CE)
US$ 0.0001
(9,900.00%)
2k
RQHTFReliq Health Technologies Inc (CE)
US$ 0.01
(9,900.00%)
63.14k
CLTHClean Tech Biofuels Inc (CE)
US$ 0.0001
(9,900.00%)
1,000
BLIBQBB Liquidating Inc (CE)
US$ 0.000001
(-99.99%)
21.08k
FLESAuto Parts 4Less Group Inc (CE)
US$ 0.000001
(-99.50%)
2.5M
DNAXDNA Brands Inc (PK)
US$ 0.000001
(-99.50%)
12.3M
FBECFBEC Worldwide Inc (CE)
US$ 0.000001
(-99.50%)
130k
CCTLCoin Citadel (PK)
US$ 0.000001
(-99.50%)
1.25k
TONRTonner One World Holdings Inc (PK)
US$ 0.0002
(0.00%)
331.58M
PHILPHI Group Inc (PK)
US$ 0.0002
(-33.33%)
292.68M
RDARRaadr Inc (PK)
US$ 0.00115
(-4.17%)
257.02M
TSOITherapeutic Solutions International Inc (PK)
US$ 0.0002
(0.00%)
253.17M
HMBLHUMBL Inc (PK)
US$ 0.001
(11.11%)
232.5M

Discusión

Ver feed completo
capgain capgain 6 minutos hace
Good morning, RR. “It’s critically important that, to the extent you can find anything that gives you an ability to be patient in this extremely dangerous and unprecedented crisis, that you do,” LOL, Just kidding :)

Straight up, I like all the home teams in the NFL this weekend. KC, D
Calvin Hobbes Calvin Hobbes 7 minutos hace
It's possible. They do need to update the GGSM one though as well and get all the info that is in filings in there as well. There is a lot of info they could add.
GGSM
QueenVic QueenVic 8 minutos hace
😂😁🫢

Elizabeth "Chief Princess of Running mouth" Warren was sooooo irrelevant at questioning the nominee Pete Hegseth (Secretary Dept of defense) and she and the cronies around her basically are people who word fight and bully their way- to no avail.
QueenVic QueenVic 19 minutos hace
I felt the same way. It's too bad that people are suffering from this

The DEI is a farce, and places hired individuals that are not qualified for the jobs it's beyond mental and physical capabilities you need to be in tip top shape no matter what and on call 24/7.

The
threewheeler threewheeler 31 minutos hace
01/15/2025 Expert Market IconCRTG The Coretec Group Inc. OTCQB Expert Market Common Stock
CRTG
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 31 minutos hace
People who bought the december offering at $3 a share sure are tasting some pain. Surprise the underwriters arent supporting the stock better.
IBRX
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 33 minutos hace
ImmunityBio has granted the underwriters a 30-day option to purchase up to an additional 5,000,000 shares of its common stock at the public offering price
I wonder if the underwriters exercised this option or not. $3 share price doesnt look to great a deal at the moment.
IBRX
martyDg martyDg 37 minutos hace
Does the big red in your nwbo position tell you it's derisked? LOL 
NWBO
GrantHorvat1 GrantHorvat1 39 minutos hace
It sure is...

If anyone wants to know what a totally clean, debt free shell looks like check out GVSI's latest annual...2024's will be filed imminently as well...the 8th of 2 years of Q's...we all know what that means and when it does it will set in motion a chain of events that will
GVSI
martyDg martyDg 41 minutos hace
Because LP is the perfect CEO of this company! She planned everything seamlessly. Per cult followers.
NWBO
GrantHorvat1 GrantHorvat1 42 minutos hace
Interesting that FUTS was touted as a clean shell...it is far from it. Veryyyyy interesting. Could work to our advantage however.

If anyone wants to know what a totally clean, debt free shell looks like check out G*VSI's latest annual...2024's will be filed imminently as well...the 8t
FUTS
Daytime_Lantern Daytime_Lantern 42 minutos hace
Hmm! Please elucidate regarding your statement ... "now I see something coming to shareholders that is really EXCITING!!"

GLTA!
BIEL
Babubd Babubd 52 minutos hace
https://www.otcmarkets.com/otcapi/company/dns/news/document/79610/content
TRII
GrantHorvat1 GrantHorvat1 52 minutos hace
Looks like around 233k in debt to 3 noteholders issued around 5 years ago. Obviously more at this point with accrued interest owed. Still outstanding as far as I can tell.

So to the people who said this was a clean shell and debt free....wrong as usual 🙄.

But th
FUTS
mick mick 52 minutos hace
thank you
MasterBlastr MasterBlastr 59 minutos hace
Schauffele withdraws from The American Express for medical reasons

https://apnews.com/article/xander-schauffele-american-express-pga-tour-d2d984c7409ac312969147f9525d5f2a
aBeezlee aBeezlee 59 minutos hace
This is a highly speculative field. Rigetti may not match top companies in benchmarks, but that doesn't mean they can't cut out their own piece of the pie. I have no idea when they'll be profitable or show significant revenue, but we can't pretend to know the future.

I'm going to kee
RGTI
SkeBallLarry SkeBallLarry 1 hora hace
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive

((( They are gettin' nervous ))) ... !!!
hyder hyder 1 hora hace
Thanks and IMO you made a very wise investment decision. I am confident we will be wealthy soon. Go $$$$$NWBO$$$$$ 
NWBO
SkeBallLarry SkeBallLarry 1 hora hace
" Thanks 'n Good Morning, CrudeOil " .. !!
mick mick 1 hora hace
is scheffele wd
SkeBallLarry SkeBallLarry 1 hora hace
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive

((( They are gettin' nervous ))) ... !!!
SkeBallLarry SkeBallLarry 1 hora hace
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive

((( They are gettin' nervous, Bull ))) ... !!!
SkeBallLarry SkeBallLarry 1 hora hace
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive
SkeBallLarry SkeBallLarry 1 hora hace
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive

Su Consulta Reciente

USOTC
PARNF
Parnell Pharmaceuticals (CE)
AQSE
RIOL.GB
Amundi MSCI Brazil UCITS...
BIT
SBAIL5
Societe Generale Effekten
BIT
P1SQ93
BNP Paribas Issuance
BIT
I07873
Intesa Sanpaolo
BIT
XB34
ETF
BIT
UC4KRS
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados